2023 2024 Student Forum > Management Forum > Main Forum

 
  #2  
2nd August 2014, 04:21 PM
Super Moderator
 
Join Date: Apr 2013
Re: GATE biotechnology last year paper

Here is the GATE biotechnology last year paper:

Q.4 The first humanized monoclonal antibody approved for the treatment of breast canceris
(A) Rituximab (B) Cetuximab (C) Bevacizumab (D) Herceptin

Q.5 Which one of the following aminoacids in proteins does NOT undergo phosphorylation?
(A) Ser (B) Thr (C) Pro (D) Tyr

Q.6 The role of an adjuvant isto
(A) prolong the persistence of antigen
(B) cross link the antigen
(C) increase the size of antigen
(D) avoid inflammation

Q.7 Endogenous antigens are presented on to the cell surface along with
(A) MHC-II (B) MHC-I (C) Fcγreceptor (D) complement receptor

Q.8 Human genome sequencing project involved the construction of genomic library in
(A)bacterial artificial chromosome (B)pBR322
(C) bacteriophage (D) pcDNA3.1

Q.9 The nucleotide analogue used in DNA sequencing by chain termination method is
(A) 1',3'-dideoxy nucleoside triphosphate
(B) 2',3'-dideoxy nucleoside triphosphate
(C) 2',4'-dideoxy nucleoside triphosphate
(D) 2',5'-dideoxy nucleoside triphosphate






Rests of the questions are in the attachment, download it freely from here:
Attached Files
File Type: pdf GATE biotechnology last year paper.pdf (265.0 KB, 46 views)


Quick Reply
Your Username: Click here to log in

Message:
Options




All times are GMT +5. The time now is 09:48 AM.


Powered by vBulletin® Version 3.8.11
Copyright ©2000 - 2024, vBulletin Solutions Inc.
SEO by vBSEO 3.6.0 PL2

1 2 3 4